The mission of this Program is to prepare a cadre of outstanding cancer epidemiologists through rigorous academic training in research methodology and the epidemiology and biology of cancer, and mentored research. Additional emphasis is placed on molecular and genetic epidemiology methods and applications. A distinguished faculty provides a variety of substantial opportunities for research experience. There are three types of trainees: Doctoral Candidates in Epidemiology includes pre-doctoral candidates either with or without a prior doctoral degree (generally clinicians) who undertake 2-3 years of coursework, in addition to research, in the course of earning a doctoral degree in Epidemiology;Clinical Researchers include physicians with specialty training in cancer preparing for careers in clinical epidemiology who undertake a one year Master's degree program in methodology followed by a year of research;and Post- doctoral Fellows who hold a prior doctoral degree in Epidemiology or in Biology and undertake mentored research (and with coursework if needed) in preparation for an academic career. Those trainee positions are generally awarded for 2 or 3 years. The number of trainee positions requested includes five pre-doctoral students and seven post-doctoral fellows, for a total of 12 trainees. The program had supported 16 trainees since 1998, but at the behest of the NIH project officer, we have reduced the requested number to 12. The Program is based in the Department of Epidemiology of the Harvard School of Public Health, and is also affiliated with the Channing Division of Network Medicine in the Department of Medicine, Brigham and Women's Hospital. A dedicated molecular epidemiology laboratory is available. This proposal continues a long history of excellence in training in cancer epidemiology at Harvard University;the current training program is now in its 37th year, with an outstanding record of achievement in training.
Knowledge about cancer epidemiology - the study of the determinants and distribution of cancer in human populations - has grown exponentially. With major advances in methodology, cancer biology and genetics, the need for well-trained highly skills researchers and clinicians in this area has never been greater. We propose, through this training grant, to continue to provide high quality cancer epidemiology training to educate the next generation of outstanding scholars and public health researchers in this vital field.
|Oh, Hannah; Boeke, Caroline E; Tamimi, Rulla M et al. (2015) The interaction between early-life body size and physical activity on risk of breast cancer. Int J Cancer 137:571-81|
|Markt, Sarah C; Valdimarsdottir, Unnur A; Shui, Irene M et al. (2015) Circadian clock genes and risk of fatal prostate cancer. Cancer Causes Control 26:25-33|
|Alemozaffar, Mehrdad; Sanda, Martin; Yecies, Derek et al. (2015) Benchmarks for operative outcomes of robotic and open radical prostatectomy: results from the Health Professionals Follow-up Study. Eur Urol 67:432-8|
|Su, Xuefen; Boeke, Caroline E; Collins, Laura C et al. (2015) Intakes of fat and micronutrients between ages 13 and 18 years and the incidence of proliferative benign breast disease. Cancer Causes Control 26:79-90|
|Tworoger, Shelley S; Rice, Megan S; Rosner, Bernard A et al. (2015) Bioactive prolactin levels and risk of breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 24:73-80|
|Sigurdardottir, Lara G; Markt, Sarah C; Rider, Jennifer R et al. (2015) Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly men. Eur Urol 67:191-4|
|Penney, Kathryn L; Sinnott, Jennifer A; Tyekucheva, Svitlana et al. (2015) Association of prostate cancer risk variants with gene expression in normal and tumor tissue. Cancer Epidemiol Biomarkers Prev 24:255-60|
|Trabert, Britton; Ness, Roberta B; Lo-Ciganic, Wei-Hsuan et al. (2014) Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst 106:djt431|
|Hernández-Díaz, Sonia; Boeke, Caroline E; Romans, Anna Thornton et al. (2014) Triggers of spontaneous preterm delivery--why today? Paediatr Perinat Epidemiol 28:79-87|
|Healey, Megan A; Hu, Rong; Beck, Andrew H et al. (2014) Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses' Health Study. Breast Cancer Res Treat 147:639-51|
Showing the most recent 10 out of 292 publications